Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder: Predictors of Change

NCT00834834 is registered in ClinicalTrials.gov with New York State Psychiatric Institute as lead sponsor.

NCT NCT00834834
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00834834 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treating Suicidal Behavior and Self-Mutilation in Borderline Personality Disorder: Predictors of Change
Lead sponsor
New York State Psychiatric Institute
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2009
Completion date
August 31, 2015
Enrollment
84 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

borderline personality disorder, suicide